Fundraising FoxAdient Medical
Pearland, US · Founded 2012 · Delaware corporation · 5 known investors
Find your way into Adient Medical
Sign up to see every warm intro you have to Adient Medical
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Adient Medical team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Adient Medical develops absorbable medical devices, including implants designed to remain safe and effective during their useful lifetime and then dissolve on their own, avoiding removal procedures and related complications.
Founders & leadership
ME
Mitchell EggersExecutive
Board
MH
Michael HoganBoard director
RT
Investors · 5
Broadview Ventureslisted by Broadview VenturesBoston
How we know: Broadview Ventures's portfolio page · a partner's Signal profile · open dataset · 5k.vc investor directory · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$18.2M disclosed across 4 rounds · 2016–2022
▶$14.3MraisedOct 2022 · 40 investors · BiotechnologyRule 506(b)
▶$14.3MraisedOct 2022 · 40 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Robert TucciDirector
- Robert MitchellDirector
- Michael HoganDirector
- Mitchell EggersExecutive Officer, Director
- Offering amount
- $14.3M
- Amount sold
- $14.3M
- First sale
- May 2022
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$711KraisedFeb 2021 · 19 investors · BiotechnologyRule 506(b)
▶$711KraisedFeb 2021 · 19 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Michael HoganDirector
- Robert TucciDirector
- Robert MitchellDirector
- Mitchell EggersExecutive Officer, Director
- Offering amount
- $2.2M
- Amount sold
- $711K
- First sale
- Jan 2021
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$1.7MraisedJul 2017 · 20 investors · BiotechnologyRule 506(b)
▶$1.7MraisedJul 2017 · 20 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- MICHAEL HOGANDirector
- ROBERT TUCCIDirector
- MITCHELL D. EGGERSExecutive Officer, Director
- Offering amount
- $3.5M
- Amount sold
- $1.7M
- First sale
- Jun 2017
- Incorporated
- Corporation, Delaware, 2012
- Federal exemptions
- 06b
▶$1.5MraisedJul 2016 · 20 investors · BiotechnologyRule 506(b)
▶$1.5MraisedJul 2016 · 20 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Michael HoganDirector
- Mitchell EggersExecutive Officer, Director
- Robert TucciDirector
- Offering amount
- $1.8M
- Amount sold
- $1.5M
- First sale
- Jul 2016
- Incorporated
- Corporation, Delaware, 2012
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 3
AngiodynamicsAngioDynamics develops and manufactures medical devices aimed at treating serious diseases and improving patient outcomes. Founded in 1988, the company serves healthcare professionals and operates globally across North America, Europe, the Middle East, and South America.
Boston ScientificBoston Scientific supports external researcher-initiated studies through its Investigator Sponsored Research program, which funds independent investigations addressing disease understanding and treatment gaps of interest to the medical community.
Entac Medical, Inc.Entac Medical develops wearable devices that apply predictive analytics and AI to biological acoustic signals to predict patient adverse events, aiming to improve patient outcomes and reduce hospital readmissions and cost of care. It serves the healthcare sector as a digital health company.
Companies working in the same space as Adient Medical.
Frequently asked questions
- What does Adient Medical do?
- Adient Medical develops absorbable medical devices, including implants designed to remain safe and effective during their useful lifetime and then dissolve on their own, avoiding removal procedures and related complications.
- Who are Adient Medical's investors?
- Adient Medical's investors include Broadview Ventures, Grant Park Ventures, Houston Angel Network, Texas HALO Fund, Texas Ventures.
- How much funding has Adient Medical raised?
- Adient Medical has disclosed $18.2M raised across 4 rounds.
- Where is Adient Medical headquartered?
- Adient Medical is headquartered in Pearland, US.